Amicus Therapeutics, Inc. (FOLD)
14.24
-0.01
(-0.07%)
USD |
NASDAQ |
Dec 30, 11:32
Amicus Therapeutics Total Liabilities (Quarterly): 638.39M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 1.558B |
| CorMedix, Inc. | 376.73M |
| ANI Pharmaceuticals, Inc. | 902.34M |
| Gilead Sciences, Inc. | 37.08B |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 868.81M |
| Shareholders Equity (Quarterly) | 230.42M |
| Debt to Equity Ratio | 1.922 |
| Current Ratio | 2.986 |
| Net Debt Paydown Yield | 0.01% |